http://www.kfpefund.com/index.php/site/index/ en dabble@kfpefund.com Copyright 2012 2012-05-01T17:31:00-05:00 http://www.kfpefund.com/index.php/site/fund_overview/ http://www.kfpefund.com/index.php/site/fund_overview/#When:16:31:00Z Since its founding in 2007, the KFBS PE Fund has made investments in 26 portfolio companies, exited 5 portfolio companies, and received 5 dividend recapitalizations. The Fund currently manages $4.4 million in assets, and holds 21 active investments, of which some are highlighted below:  Investments, KFBSF I Investments 2012-05-01T16:31:00-05:00 http://www.kfpefund.com/index.php/site/clearside_biomedical_closes_4mm_venture_financing/ http://www.kfpefund.com/index.php/site/clearside_biomedical_closes_4mm_venture_financing/#When:14:24:00Z Ophthalmic startup Clearside Biomedical and Hatteras Venture Partners announced they have launched the company with a $4,000,000 Series A venture financing to fund the initial development of Clearside Biomedical’s ocular microinjection platform and initial clinical testing of Clearside Biomedical’s lead product for Macular Edema and Retinal Vein Occlusion. Clearside Biomedical’s proprietary ocular microinjection platform has been designed to non-surgically deliver drugs to an area of the eye referred to as the suprachoroidal space which allows a novel way of dosing of therapeutics to the tissues of the posterior segment of the eye and retina. News 2012-02-16T14:24:00-05:00 http://www.kfpefund.com/index.php/site/clearside_biomedical/ http://www.kfpefund.com/index.php/site/clearside_biomedical/#When:14:01:00Z Clearside Biomedical is an ophthalmic company specializing in the research, development and commercialization of therapeutic products through a proprietary ocular microinjection platform that targets the individual compartments of the eye. Currently, Clearside Biomedical is focused on its initial product candidate, CLS1001, under development for retinal applications through the delivery of proven therapeutics to the suprachoroidal space. Clearside Biomedical was founded by an executive team with extensive development and revenue growth expertise, focused on improving the delivery of therapeutic agents to improve standard of care for patients with sight threatening disease. Investments, KFBSF I Investments 2012-02-16T14:01:00-05:00 http://www.kfpefund.com/index.php/site/pennant_park_investment_corporation/ http://www.kfpefund.com/index.php/site/pennant_park_investment_corporation/#When:16:58:00Z PennantPark Investment Corporation (Nasdaq: PNNT) is an externally managed investment company that has elected to be treated as a business development company under the Investment Company Act of 1940 and as a regulated investment company, or RIC. PennantPark’s investment objectives are to generate both current income and capital appreciation through debt and equity investments. They invest primarily in U.S. middle-market private companies in the form of senior secured loans, mezzanine debt and equity investments. The companies in which PennantPark invests are typically highly leveraged, often as a result of leveraged buy-outs or other recapitalization transactions. Their investments of senior secured loans, mezzanine loans and other investments will range between $10 million and $50 million each, although this investment size will vary proportionately with the size of their capital base Investments, KFBSF I Exited Deals 2012-02-14T16:58:00-05:00 http://www.kfpefund.com/index.php/site/z_capital_and_james_zenni_provide_100k_grant_to_unc_kenan_flagler/ http://www.kfpefund.com/index.php/site/z_capital_and_james_zenni_provide_100k_grant_to_unc_kenan_flagler/#When:16:30:00Z Z Capital Partners and James J. Zenni have provided a $100,000 grant to the University of North Carolina’s Kenan-Flagler Business School. The grant will support PE education for MBA and undergraduate business students. News 2012-02-14T16:30:00-05:00 http://www.kfpefund.com/index.php/site/xl_associates_inc/ http://www.kfpefund.com/index.php/site/xl_associates_inc/#When:16:56:01Z Founded in 1989, XL is a leading and award-winning government services provider focused on mission-critical global initiatives across a diverse range of federal agencies. XL’s core service offerings include acquisition life cycle support ("ALCS"), grants management ("GM"), and specialized program management ("SPM"). The ALCS and GM divisions assist federal government agencies in procuring goods and services by managing the planning, execution, and administration of the contracting and grants processes. The SPM division provides support in global stabilization operations and mission support planning through worldwide deployment on some of our country’s most important foreign policy and international humanitarian initiatives.  Investments 2012-02-07T16:56:01-05:00 http://www.kfpefund.com/index.php/site/sharecare_announces_14mm_equity_raise/ http://www.kfpefund.com/index.php/site/sharecare_announces_14mm_equity_raise/#When:17:00:00Z Sharecare announced a $14 million growth equity financing led by Galen Partners.  The proceeds of the financing will enable Sharecare to accelerate the development of innovative programs, services and tools that foster healthier living and unite people across the healthcare continuum to deliver and receive optimal care.  Sharecare also acquired The Little Blue Book (TLBB) from Galen Partners as part of the deal, and Jeff Arnold will expand his role as CEO.  News 2012-01-24T17:00:00-05:00 http://www.kfpefund.com/index.php/site/apollo_investment_corporation/ http://www.kfpefund.com/index.php/site/apollo_investment_corporation/#When:15:20:01Z Apollo Investment Corporation is a publicly traded business development company (BDC) that has been investing for over two decades in undervalued companies with sound business models.  Apollo primarily invests in companies with a market leading position with strong free cash flow and experienced management team.  Since 1990, they have invested in over 150 companies with more than 100 different financial sponsors.  About 60% of their portfolio consists of subordinated debt of middle market companies whereas 30% is senior secured loans with the final 10% being equity and warrants on the basis of its debt investments.  Investments, KFBSF I Investments 2011-12-20T15:20:01-05:00 http://www.kfpefund.com/index.php/site/sharecare/ http://www.kfpefund.com/index.php/site/sharecare/#When:17:51:00Z Sharecare is an interactive social Q & A platform providing consumers expert medical information for health and wellness. Sharecare was launched in 2010 by WebMD founder Jeff Arnold and Dr. Mehmet Oz in partnership with Discovery Communications, Harpo Productions, HSW International, and Sony Pictures Television.  Based in Atlanta, GA, Sharecare’s mission is to greatly simplify the search for high-quality healthcare information and answer the world’s questions of health. Sharecare’s content contributors include hospitals, MDs, non-profits, healthcare companies and active health consumers.  Investments, KFBSF I Investments 2011-12-08T17:51:00-05:00 http://www.kfpefund.com/index.php/site/k2_industrial_services/ http://www.kfpefund.com/index.php/site/k2_industrial_services/#When:17:24:00Z K2 Industrial Services is one of the largest outsourced industrial services providers in the U.S. and performs cleaning, coating, insulation, scaffolding and roofing work in more than 700 facilities.  The Company serves a diverse array of customers (over 500) in a number of industries, including refining, petro-chemical, speciality chemical, power generation, steel and paper.  The Company has 22 branch locations across the U.S., allowing it to serve Fortune 500 customers nationwide.  K2 has significant operations in the Great Lakes, the Gulf Coast, Southern California and the Mid-Atlantic. Investments 2011-12-06T17:24:00-05:00